Optimizing immunotherapy for colorectal cancer.

Nat Rev Gastroenterol Hepatol

Molecular Pharmacology Program, Sloan Kettering Institute and Gastrointestinal Oncology Service, Memorial Hospital, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Published: February 2022

Important colorectal cancer (CRC) studies in 2021, including a new standard of care for first-line treatment of MSI-H–dMMR metastatic CRC, single-cell and spatial analysis of primary tumours and investigations of diet in preclinical models of cancer initiation, have provided novel insights into the CRC immune microenvironment.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487162PMC
http://dx.doi.org/10.1038/s41575-021-00569-4DOI Listing

Publication Analysis

Top Keywords

colorectal cancer
8
optimizing immunotherapy
4
immunotherapy colorectal
4
cancer colorectal
4
cancer crc
4
crc studies
4
studies 2021
4
2021 including
4
including standard
4
standard care
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!